MedPath

Comparing drug versus drug with catheter in low risk first time pregnant mothers for labor induction

Completed
Conditions
Pregnant women who are planned for induction of labor
Registration Number
CTRI/2018/08/015553
Lead Sponsor
CMC vellore
Brief Summary

Induction of labour is the stimulation of uterine contractions before the spontaneous

 onset of labour, in the presence or absence of membranes (1).

 Induction of labour is indicated in cases where continuation of pregnancy poses more

 risk than benefit to the mother or/and fetus. Some examples of these situations are,

 rupture of membranes before the start of uterine contractions, oligohydramnios,

 gestational hypertension, intrauterine growth restriction, maternal indications such as

 diabetes mellitus/ chronic hypertension (2). Easy availability of ripening agents, and

 patient  request also play an important role in increasing rates of induction of labour

 (3).  Electively inducing labour for convenience to the obstetricians schedule has also

 been recognized as a major contributing factor (4).

  **Induction of labour at term**: Continuation of pregnancy beyond 42 weeks is

 associated with complications to the mother and the fetus.  A Cochrane review studied

 22 trials that induced labour between 37 and 42 weeks of gestation, compared to

 waiting for spontaneous labour  (5). It was found that earlier induction resulted in

 fewer perinatal deaths, less meconium aspiration and fewer caesareans than the policy

 of waiting.  A systematic review by Caughey et al which included 11 randomised

 control trials suggested that elective induction of labour after 41 weeks resulted in a

 decreased risk for caesarean delivery and meconium stained amniotic fluid (6).

**Prevalence of Induction of Labour**: Induction rates seem to have increased in the

 last decade. A study done in the US showed that the rate of induction of labour has

 increased nationwide from 9.5% to 19.4% between the years 1990 and 1998 (3).

 Increased rates of medically indicated inductions did not contribute to this rise as

 much as marginally indicated, or elective inductions. These contribute to at least half

 of all inductions, and induction of labour in nulliparas with an unfavourable cervix

 results in rising rates of caesarean sections (7).

 A national survey was done in the USA by Childhood Connection to ascertain the

 experiences of women during pregnancy and labour (8) . 2400 women completed a

 detailed online questionnaire. 41% of these women underwent induction of labour.

 The most common rationale given to these mothers for inducing labour was that the

 baby was overdue (18%), and a maternal health problem that required a quick delivery

 (18%).

  In Christian Medical College, Vellore, incidence of induction of labour whenever

indicated, is about 15- 20%. The rate of primary LSCS is about 18-24%, failed

induction accounting for 6-10% of cases

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
608
Inclusion Criteria

1 Primigravida 2 37 completed weeks to 40+6 weeks of gestation 3 Low risk pregnancy 4 Singleton, cephalic presentation, live fetes 5 Intact membranes 6 Bishops Score <6 (not in labour) •Reactuve preinduction CTG.

Exclusion Criteria

1 Multigravida 2 Bishops Score >6 3 High Risk Pregnancy 4 Rupture of membranes 5 Maternal fever 6 Non vertex presentation 7 Non reassuring CTG 8 Reinduction (previously unsuccessful induction of labour) 9 Allergy to Misoprostol/ latex 10 Previous LSCS/myomectomy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Induction to delivery intervalonce
Secondary Outcome Measures
NameTimeMethod
Rate of vaginal deliveryRate of primary LSCS

Trial Locations

Locations (1)

Christian Medical College

🇮🇳

Vellore, TAMIL NADU, India

Christian Medical College
🇮🇳Vellore, TAMIL NADU, India
Dr Jessie Lionel
Principal investigator
9566804173
jessielionel@cmcvellore.ac.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.